PA5-16693

antibody from Invitrogen Antibodies

Targeting: CD8B CD8B1

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-16693

Provider

Invitrogen Antibodies

Product name

CD8 Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

PA5-16693 targets CD8 in IHC (P) applications and shows reactivity with Human samples.

Concentration

0.5 mg/mL

References

Submitted references

The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.

Baras AS, Drake C, Liu JJ, Gandhi N, Kates M, Hoque MO, Meeker A, Hahn N, Taube JM, Schoenberg MP, Netto G, Bivalacqua TJ
Oncoimmunology 2016 May;5(5):e1134412

---

MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.

Cebrián C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, Kanter E, Budhu S, Mandelbaum J, Vonsattel JP, Zecca L, Loike JD, Sulzer D
Nature communications 2014 Apr 16;5:3633

---

Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisy.

Caramori G, Lasagna L, Casalini AG, Adcock IM, Casolari P, Contoli M, Tafuro F, Padovani A, Chung KF, Barnes PJ, Papi A, Rindi G, Bertorelli G
PloS one 2011;6(7):e22637

Immunohistochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Formalin-fixed, paraffin-embedded human tonsil stained with CD8 using peroxidase-conjugate and AEC. Note cell membrane staining of T cells